Beneficient
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2M | $-42.4M | $18.7M | $-2.8M | $-12.6M | $-31.0M | $4.4M | $8.6M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-377.0K | $-59.9M | $3.9M | $-17.9M | $-92.6M | $-45.3M | $-9.5M | $-13.7M |
| Operating Margin | -3.1% | 141.3% | 21.1% | 646.5% | 734.0% | 146.3% | -215.3% | -160.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-59.9M | $5.9M | $-17.9M | $-92.6M | $-45.3M | $-9.5M | $9.7M |
| Income Tax Expense | $0 | $171.0K | $0 | $43.0K | $0 | $-661.0K | $713.0K | $0 |
| Net Income | $-6.8M | $-24.4M | $19.9M | $-17.9M | $-65.1M | $5.7M | $-8.6M | $9.7M |
| Net Margin | -55.8% | 57.4% | 106.7% | 648.1% | 515.5% | -18.5% | -195.5% | 113.9% |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |